BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 37171958)

  • 1. Deep proteomics identifies shared molecular pathway alterations in synapses of patients with schizophrenia and bipolar disorder and mouse model.
    Aryal S; Bonanno K; Song B; Mani DR; Keshishian H; Carr SA; Sheng M; Dejanovic B
    Cell Rep; 2023 May; 42(5):112497. PubMed ID: 37171958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic analysis of membrane microdomain-associated proteins in the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder reveals alterations in LAMP, STXBP1 and BASP1 protein expression.
    Behan AT; Byrne C; Dunn MJ; Cagney G; Cotter DR
    Mol Psychiatry; 2009 Jun; 14(6):601-13. PubMed ID: 18268500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postmortem transcriptional profiling reveals widespread increase in inflammation in schizophrenia: a comparison of prefrontal cortex, striatum, and hippocampus among matched tetrads of controls with subjects diagnosed with schizophrenia, bipolar or major depressive disorder.
    Lanz TA; Reinhart V; Sheehan MJ; Rizzo SJS; Bove SE; James LC; Volfson D; Lewis DA; Kleiman RJ
    Transl Psychiatry; 2019 May; 9(1):151. PubMed ID: 31123247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Similarities in Cortical Transcriptome Alterations Between Schizophrenia and Bipolar Disorder Are Related to the Presence of Psychosis.
    Enwright JF; Lewis DA
    Schizophr Bull; 2021 Aug; 47(5):1442-1451. PubMed ID: 33442739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative serum proteomic analysis of a selected protein panel in individuals with schizophrenia and bipolar disorder and the impact of genetic risk burden on serum proteomic profiles.
    Oraki Kohshour M; Kannaiyan NR; Falk AJ; Papiol S; Heilbronner U; Budde M; Kalman JL; Schulte EC; Rietschel M; Witt S; Forstner AJ; Heilmann-Heimbach S; Nöthen MM; Spitzer C; Malchow B; Müller T; Wiltfang J; Falkai P; Schmitt A; Rossner MJ; Nilsson P; Schulze TG
    Transl Psychiatry; 2022 Nov; 12(1):471. PubMed ID: 36351892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Commonality in dysregulated expression of gene sets in cortical brains of individuals with autism, schizophrenia, and bipolar disorder.
    Guan J; Cai JJ; Ji G; Sham PC
    Transl Psychiatry; 2019 May; 9(1):152. PubMed ID: 31127088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The miR-124-AMPAR pathway connects polygenic risks with behavioral changes shared between schizophrenia and bipolar disorder.
    Namkung H; Yukitake H; Fukudome D; Lee BJ; Tian M; Ursini G; Saito A; Lam S; Kannan S; Srivastava R; Niwa M; Sharma K; Zandi P; Jaaro-Peled H; Ishizuka K; Chatterjee N; Huganir RL; Sawa A
    Neuron; 2023 Jan; 111(2):220-235.e9. PubMed ID: 36379214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A psychiatric disease-related circular RNA controls synaptic gene expression and cognition.
    Zimmerman AJ; Hafez AK; Amoah SK; Rodriguez BA; Dell'Orco M; Lozano E; Hartley BJ; Alural B; Lalonde J; Chander P; Webster MJ; Perlis RH; Brennand KJ; Haggarty SJ; Weick J; Perrone-Bizzozero N; Brigman JL; Mellios N
    Mol Psychiatry; 2020 Nov; 25(11):2712-2727. PubMed ID: 31988434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific subcellular changes in oxidative stress in prefrontal cortex from patients with bipolar disorder.
    Andreazza AC; Wang JF; Salmasi F; Shao L; Young LT
    J Neurochem; 2013 Nov; 127(4):552-61. PubMed ID: 23692477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondria DNA copy number, mitochondria DNA total somatic deletions, Complex I activity, synapse number, and synaptic mitochondria number are altered in schizophrenia and bipolar disorder.
    Das SC; Hjelm BE; Rollins BL; Sequeira A; Morgan L; Omidsalar AA; Schatzberg AF; Barchas JD; Lee FS; Myers RM; Watson SJ; Akil H; Bunney WE; Vawter MP
    Transl Psychiatry; 2022 Aug; 12(1):353. PubMed ID: 36042222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrasting changes in DRD1 and DRD2 splice variant expression in schizophrenia and affective disorders, and associations with SNPs in postmortem brain.
    Kaalund SS; Newburn EN; Ye T; Tao R; Li C; Deep-Soboslay A; Herman MM; Hyde TM; Weinberger DR; Lipska BK; Kleinman JE
    Mol Psychiatry; 2014 Dec; 19(12):1258-66. PubMed ID: 24322206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A large-scale integrative analysis of GWAS and common meQTLs across whole life course identifies genes, pathways and tissue/cell types for three major psychiatric disorders.
    Zhao Y; Liang X; Zhu F; Wen Y; Xu J; Yang J; Ding M; Cheng B; Ma M; Zhang L; Cheng S; Wu C; Wang S; Wang X; Ning Y; Guo X; Zhang F
    Neurosci Biobehav Rev; 2018 Dec; 95():347-352. PubMed ID: 30339835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diminished levels of the chemokine fractalkine in post-mortem prefrontal cortex in schizophrenia but not bipolar disorder.
    Hill SL; Shao L; Beasley CL
    World J Biol Psychiatry; 2021 Feb; 22(2):94-103. PubMed ID: 32295454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-wide analysis reveals genetic overlap between alcohol use behaviours, schizophrenia and bipolar disorder and identifies novel shared risk loci.
    Wiström ED; O'Connell KS; Karadag N; Bahrami S; Hindley GFL; Lin A; Cheng W; Steen NE; Shadrin A; Frei O; Djurovic S; Dale AM; Andreassen OA; Smeland OB
    Addiction; 2022 Mar; 117(3):600-610. PubMed ID: 34472679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic basis of psychopathological dimensions shared between schizophrenia and bipolar disorder.
    Corponi F; Bonassi S; Vieta E; Albani D; Frustaci A; Ducci G; Landi S; Boccia S; Serretti A; Fabbri C
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Mar; 89():23-29. PubMed ID: 30149091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deficits in axon-associated proteins in prefrontal white matter in bipolar disorder but not schizophrenia.
    Shao L; Golbaz K; Honer WG; Beasley CL
    Bipolar Disord; 2016 Jun; 18(4):342-51. PubMed ID: 27218831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for disease and antipsychotic medication effects in post-mortem brain from schizophrenia patients.
    Chan MK; Tsang TM; Harris LW; Guest PC; Holmes E; Bahn S
    Mol Psychiatry; 2011 Dec; 16(12):1189-202. PubMed ID: 20921955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormalities in Prefrontal Cortical Gene Expression Profiles Relevant to Schizophrenia in MK-801-Exposed C57BL/6 Mice.
    Zhao J; Liu X; Huo C; Zhao T; Ye H
    Neuroscience; 2018 Oct; 390():60-78. PubMed ID: 30102956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DCLK1 variants are associated across schizophrenia and attention deficit/hyperactivity disorder.
    Håvik B; Degenhardt FA; Johansson S; Fernandes CP; Hinney A; Scherag A; Lybæk H; Djurovic S; Christoforou A; Ersland KM; Giddaluru S; O'Donovan MC; Owen MJ; Craddock N; Mühleisen TW; Mattheisen M; Schimmelmann BG; Renner T; Warnke A; Herpertz-Dahlmann B; Sinzig J; Albayrak Ö; Rietschel M; Nöthen MM; Bramham CR; Werge T; Hebebrand J; Haavik J; Andreassen OA; Cichon S; Steen VM; Le Hellard S
    PLoS One; 2012; 7(4):e35424. PubMed ID: 22539971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A combined metabonomic and proteomic approach identifies frontal cortex changes in a chronic phencyclidine rat model in relation to human schizophrenia brain pathology.
    Wesseling H; Chan MK; Tsang TM; Ernst A; Peters F; Guest PC; Holmes E; Bahn S
    Neuropsychopharmacology; 2013 Nov; 38(12):2532-44. PubMed ID: 23942359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.